GS-441524 is a nucleoside analog compound frequently referenced in veterinary antiviral programs related to feline infectious peritonitis (FIP). It is supplied as an injectable formulation designed for use within structured veterinary treatment plans.
The 20mg/ml concentration combined with a 7ml vial size provides a balanced option for dosage calculation based on body weight.
Injectable administration allows the compound to enter systemic circulation directly, which is often preferred during long treatment protocols.
This product is manufactured in China and packaged in sealed vials suitable for veterinary distribution and professional animal healthcare use.
| Item | Specification |
|---|---|
| Product Name | GS-441524 Injection |
| CAS Number | 1191237-69-0 |
| Concentration | 20mg/ml |
| Dosage Form | Injectable Solution |
| Vial Volume | 7ml per vial |
| Storage Condition | Room Temperature |
| Shelf Life | 12 Months from Manufacturing Date |
| Country of Manufacture | China |
| Intended Use | Treatment for Cat FIP |
Each vial is clearly labeled with batch information and expiration date to support product traceability.
Feline infectious peritonitis is a serious viral condition in cats that originates from mutations of feline coronavirus. The disease can develop into different clinical forms depending on how the virus affects the body.
Veterinary professionals typically recognize the following categories:
Wet FIP (Effusive Form)
This type often involves fluid accumulation in the abdomen or chest cavity.
Dry FIP (Non-Effusive Form)
The disease progresses without major fluid buildup but may affect internal organs.
Ocular FIP
Inflammation may occur in eye tissues.
Neurological FIP
In some cases the nervous system becomes involved, which may require adjustments in dosage protocols.
Because the disease can vary significantly between patients, treatment strategies often depend on body weight, clinical symptoms, and veterinarian evaluation.
The dosage of GS-441524 injection is generally calculated according to the cat’s body weight and the specific type of FIP involved.
| Condition | Recommended Dosage |
|---|---|
| Wet FIP | 0.3 ml per kg body weight + 0.1 ml residue |
| Dry FIP | 0.4 ml per kg body weight + 0.1 ml residue |
| Eye / Nerve Involvement | 0.5 ml per kg body weight + 0.1 ml residue |
| Recurrence Cases | 0.6 ml per kg body weight + 0.1 ml residue |
Weight monitoring during treatment is important to maintain accurate dosing throughout the treatment period.
The 20mg/ml 7ml GS-441524 injection offers several practical advantages for veterinary use:
Standard concentration suitable for common FIP treatment protocols
7ml vial size provides flexibility in multi-day dosing schedules
Injectable delivery allows systemic distribution
Clear packaging labels for identification and record keeping
Storage at room temperature simplifies logistics and handling
These characteristics make the product suitable for veterinary clinics, animal hospitals, and distributors involved in feline healthcare support.
To preserve product quality:
Store in a dry environment at room temperature
Protect from excessive heat and direct sunlight
Keep the vial tightly sealed when not in use
Use sterile techniques during administration
When stored under recommended conditions, the product remains stable for up to 12 months from the manufacturing date.
GS-441524 injection is commonly supplied to:
Veterinary clinics
Animal hospitals
Cat rescue organizations
Veterinary pharmaceutical distributors
Professional veterinary supervision is recommended when determining treatment plans and dosage schedules.
This product is intended for veterinary use only.
Administration and treatment decisions should be made by qualified veterinary professionals according to the cat’s medical condition and local regulatory guidelines.
